These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29988762)

  • 21. Evaluating erectile dysfunction: oral sildenafil versus intracavernosal injection of papaverine.
    Viswaroop B; B A; Gopalakrishnan G
    Natl Med J India; 2005; 18(6):299-301. PubMed ID: 16483029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury.
    Bodner DR; Haas CA; Krueger B; Seftel AD
    Urology; 1999 Jan; 53(1):199-202. PubMed ID: 9886612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-injection devices for intracavernosal pharmacotherapy: operational classification and safety considerations.
    Pescatori ES; Calpista A; Artibani W; Pagano F; Calabro A
    Int J Impot Res; 1996 Jun; 8(2):53-7; discussion 57-8. PubMed ID: 8858390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of intracavernosal avanafil, a newer phosphodiesterase-5 inhibitor, on neonatal type 2 diabetic rats with erectile dysfunction.
    Yilmaz D; Bayatli N; Un O; Kadowitz PJ; Sikka SC; Gur S
    Urology; 2014 Feb; 83(2):508.e7-12. PubMed ID: 24331245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracavernosal injection therapy. Does it still have a role in erectile dysfunction?
    Chew KK
    Aust Fam Physician; 2001 Jan; 30(1):43-6. PubMed ID: 11211711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preference for oral sildenafil or intracavernosal injection in patients with erectile dysfunction already using intracavernosal injection for > 1 year.
    Kim SC; Chang IH; Jeon HJ
    BJU Int; 2003 Aug; 92(3):277-80. PubMed ID: 12887483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy for erectile dysfunction.
    Eardley I; Donatucci C; Corbin J; El-Meliegy A; Hatzimouratidis K; McVary K; Munarriz R; Lee SW
    J Sex Med; 2010 Jan; 7(1 Pt 2):524-40. PubMed ID: 20092451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracavernous Injection of Human Umbilical Cord Blood Mononuclear Cells Improves Erectile Dysfunction in Streptozotocin-Induced Diabetic Rats.
    Cengiz T; Kaya E; Oral DY; Ozakca I; Bayatli N; Karabay AZ; Ensari TA; Karahan T; Yilmaz E; Gur S
    J Sex Med; 2017 Jan; 14(1):50-58. PubMed ID: 28065360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracavernosal prostaglandin E1 self vs office injection therapy in patients with erectile dysfunction.
    El-Sakka AI
    Int J Impot Res; 2006; 18(2):180-5. PubMed ID: 16163370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Empirical vs Risk-Based Approach Algorithm to Intracavernosal Injection Therapy: A Prospective Study.
    Bernie HL; Segal R; Le B; Burnett A; Bivalacqua TJ
    Sex Med; 2017 Mar; 5(1):e31-e36. PubMed ID: 28190453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracavernosal Injection for the Diagnosis, Evaluation, and Treatment of Erectile Dysfunction: A Review.
    Belew D; Klaassen Z; Lewis RW
    Sex Med Rev; 2015 Mar; 3(1):11-23. PubMed ID: 27784568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin E1 as treatment for erectile failure in elderly men.
    Godschalk MF; Chen J; Katz PG; Mulligan T
    J Am Geriatr Soc; 1994 Dec; 42(12):1263-5. PubMed ID: 7983289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasoactive intestinal polypeptide and phentolamine mesylate administered by autoinjector in the treatment of patients with erectile dysfunction resistant to other intracavernosal agents.
    Dinsmore WW; Alderdice DK
    Br J Urol; 1998 Mar; 81(3):437-40. PubMed ID: 9523666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delivery of intracavernosal therapies using needle-free injection devices.
    O'Kane D; Gibson L; du Plessis J; Davidson A; Bolton D; Lawrentschuk N
    Int J Impot Res; 2017 Nov; 29(6):225-228. PubMed ID: 28747647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaco Penile Duplex Ultrasonography in the Evaluation of Erectile Dysfunction.
    Mutnuru PC; Ramanjaneyulu HK; Susarla R; Yarlagadda J; Devraj R; Palanisamy P
    J Clin Diagn Res; 2017 Jan; 11(1):TC07-TC10. PubMed ID: 28274021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracavernosal injection and intraurethral therapy for erectile dysfunction.
    Leungwattanakij S; Flynn V; Hellstrom WJ
    Urol Clin North Am; 2001 May; 28(2):343-54. PubMed ID: 11402586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).
    Hatzimouratidis K; Salonia A; Adaikan G; Buvat J; Carrier S; El-Meliegy A; McCullough A; Torres LO; Khera M
    J Sex Med; 2016 Apr; 13(4):465-88. PubMed ID: 27045254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term histopathologic effects of different intracavernosal agents on corpus cavernosum and antifibrotic activity of intracavernosal verapamil: an experimental study.
    Sahin M; Başar MM; Bozdoğan O; Atan A
    Urology; 2001 Sep; 58(3):487-92. PubMed ID: 11549511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The additive erectile recovery effect of brain-derived neurotrophic factor combined with vascular endothelial growth factor in a rat model of neurogenic impotence.
    Chen KC; Minor TX; Rahman NU; Ho HC; Nunes L; Lue TF
    BJU Int; 2005 May; 95(7):1077-80. PubMed ID: 15839936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracavernosal pharmacotherapeutic advances toward a new millennium.
    Knight M; Nehra A
    Drugs Today (Barc); 2000; 36(2-3):101-11. PubMed ID: 12879107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.